[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622834":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":47,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":63,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":10,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"NSCLC with neoadjuvant therapy but without surgery",null,{"label":12,"type":10,"description":10,"interventionNames":10},"NSCLC with neoadjuvant therapy and surgery",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Minghao Hu","CONTACT","8613396366466","huminghao2010@126.com",[20,36],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Tongji hospital","RECRUITING","Wuhan","Hubei","430030","China","CN",{"type":29,"coordinates":30},"Point",[31,32],114.26667,30.58333,{"lat":32,"lon":31},[35],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":10},{"facility":37,"status":22,"city":38,"state":39,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":40,"geoPoint":44,"contacts":45},"Sir Run Run Shaw Hospital","Hangzhou","Zhejiang",{"type":29,"coordinates":41},[42,43],120.16142,30.29365,{"lat":43,"lon":42},[46],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Qian Chu","Director of the Thoracic Oncology Department","100622834","prediction-of-outcome-to-neoadjuvant-therapy-in-non-small-cell-lung-cancernsclc-100622834",false,"NCT07388771","Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）","A Study on Multimodal Data Prediction of Outcome to Neoadjuvant Therapy in NSCLC","Inclusion Criteria:\n\n1. pathologically diagnosed non-small cell lung cancer\n2. The treatment plan is：receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection\n\nExclusion Criteria:\n\n1. recurrent or metastatic lung cancer;\n2. patients with other primary tumors","ALL","18 Years",{"count":61,"type":62},500,"ESTIMATED","6 Months","OBSERVATIONAL","This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC.\n\nThe core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?",[67,68],"NSCLC","Neoadjuvant Therapy","2026-03-18",{"date":71,"type":72},"2026-03-19","ACTUAL",{"date":74,"type":72},"2025-12-01",{"date":76,"type":62},"2026-10",{"name":49,"class":6},2]